Nomograms predicting prognosis of patients with pathological stages T1N2-3 and T3N0 gastric cancer

BACKGROUND: Patients with pathological stages T1N2-3 (pT1N2-3) and pT3N0 gastric cancer (GC) have not been routinely included in the target population for postoperative chemotherapy according to the Japanese Gastric Cancer Treatment Guideline, and their prognosis is significantly different. AIM: To...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yu-Fei, Yin, Xin, Fang, Tian-Yi, Wang, Yi-Min, Zhang, Dao-Xu, Zhang, Yao, Wang, Xi-Bo, Wang, Hao, Xue, Ying-Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Retrospective Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8908342/
https://www.ncbi.nlm.nih.gov/pubmed/35317546
http://dx.doi.org/10.4240/wjgs.v14.i2.143

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8908342/
https://www.ncbi.nlm.nih.gov/pubmed/35317546
http://dx.doi.org/10.4240/wjgs.v14.i2.143

Ejemplares similares